{"id":"W2804360725","doi":"10.1097/rhu.0000000000000786","title":"Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs","year":2018,"lang":"en","type":"review","venue":"JCR Journal of Clinical Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Janus kinase inhibitor; Rheumatoid arthritis; Placebo; Adalimumab; Adverse effect; Internal medicine; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00654345,0.0008414675,0.007818853,0.001450696,0.000170572,0.0001385251,0.0006205194,0.0006500421,0.0001519807],"category_scores_gemma":[0.0145253,0.00060123,0.0008861947,0.0007582917,0.0009761195,0.000368225,0.0003052516,0.002315855,0.0001641645],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001321215,"about_ca_system_score_gemma":0.00241104,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002970291,"about_ca_topic_score_gemma":0.0000225331,"domain_scores_codex":[0.987681,0.002919639,0.006162699,0.000884494,0.001258507,0.00109364],"domain_scores_gemma":[0.9876277,0.005957584,0.002740382,0.0008378455,0.0008586466,0.001977866],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0203485,0.000783518,0.04312139,0.00450028,0.0007920752,0.0006745456,0.0004311089,2.977173e-7,6.362889e-8,0.00009979798,0.000841787,0.9284067],"study_design_scores_gemma":[0.02657532,0.008069235,0.03342367,0.2400464,0.0001336974,0.00263607,0.000183107,0.00001581541,2.305982e-7,0.000307891,0.6876591,0.0009494226],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.4011127,0.5969413,0.00003513397,0.0004511637,0.0003684557,0.0009852223,0.00005397138,0.00002221374,0.00002982196],"genre_scores_gemma":[0.05152797,0.9469502,0.001034641,0.0001706162,0.0000558482,0.00005130748,0.0000411433,0.0001402899,0.00002796072],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9274572,"threshold_uncertainty_score":0.9999858,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04898100704138098,"score_gpt":0.3946032902520369,"score_spread":0.3456222832106559,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}